ABSTRACT Drug sensitivity tests were performed for ethambutol, rifampicin, streptomycin, and isoniazid both alone and in paired combinations, on 16 strains of Mycobacterium avium intracellulare, seven strains of Mycobacterium xenopi, and eight strains of Mycobacterium malmoense. Most strains were resistant to the individual drugs, but all strains of M malmoense, 86% of M xenopi, and 31% of M avium intracellulare were completely suppressed by the lowest concentrations of ethambutol and rifampicin when the two drugs were combined in vitro. Streptomycin combined with ethambutol or with rifampicin in the lowest combined concentrations suppressed 50% and 62% respectively of strains of M malmoense. All strains of M xenopi were suppressed by the lowest combined concentrations of streptomycin with rifampicin. Combinations with isoniazid were less effective. It is postulated that similar effects in vivo might account for the satisfactory clinical response seen in patients with disease caused by these mycobacteria who have received treatment with combinations of standard antituberculosis drugs despite in vitro resistance to the individual agents.
Introduction
The response to treatment with antituberculosis drugs is less predictable in patients with pulmonary infection caused by non-tuberculous mycobacteria than in those with disease caused by Mycobacterium tuberculosis. Serious coexistent pulmonary disease or compromised immunity undoubtedly contribute to the poor prognosis in many patients. In others, however, treatment with toxic second line drugs, given in regimens tailored to the results of in vitro sensitivity tests, has led to poor compliance by the patient and hence treatment failure.' Decisions about treatment are complicated by the usual reports of in vitro resistance to first line drugs, which is characteristic of many of these organisms. Paradoxically, prolonged treatment with combinations of standard antituberculosis drugs is often successful despite in vitro resistance to the individual agents.2 3 The reason for this is not clear, although the discrepancy may reflect the limitations of the method used for sensitivity testing, which uses the concept of modal resistance. An alternative explanation is that drugs given in combination interact, and organisms resistant to the individual drugs become susceptible to their combined actions.
To investigate this hypothesis we have studied the effect of combining pairs of standard drugs in vitro on the sensitivity patterns of strains of Mycobacterium malmoense, Mycobacterium xenopi, and Mycobacterium avium intracellulare.
Methods
Sensitivity tests were performed on 16 strains of M avium intracellulare, seven strains of M xenopi, and eight strains of M malmoense. Twenty of the strains had originally been cultured from sputum specimens and sent to the Mycobacterium Reference Unit in Cardiff. Another six strains of M avium intracellulare were cultured from resected lymph nodes, another two from lung sections taken at necropsy, and one other from pleural fluid.
Routine techniques for the examination of strains, as described by Marks, 4 were used throughout the study. Briefly, strains were subcultured on slopes of glycerol egg medium, and after three weeks incubation suspensions were made by transferring a 2 mm 838
Combined versus single antituberculosis drugs on the sensitivity patterns of non-tuberculous mycobacteria 839 loopful of growth into screw capped bottles containing 05 ml of M 15 phosphate buffer, pH 7 0, and two nails. After being stirred on a magnetic stirrer the resultant suspension was diluted 1:5 in sterile water and then inoculated in 3 s L I aliquots on to control and drug slopes. These were incubated in the dark at 37°C for three weeks.
Sensitivity of bacterial growth and compared with the control tubes. Absence of visible bacterial colonies was accepted as the end point, although small discrete specks were regarded as representing a negative result.
Results
The results of the sensitivity tests for both single drugs and drug combinations are shown in tables 2-4. The percentage of strains that grew in tubes containing single drugs are shown adjacent to the tube numbers and the percentage of strains that grew in tubes containing drug combinations are entered on the chequerboard.
The overall results show that drugs in combination were more effective than the individual agents in suppressing bacterial growth.
M malmoense (table 2) Rifampicin combined with ethambutol completely suppressed all strains of M malmoense even at the lowest combined concentrations (tube 2 x 2), although 88% of strains were resistant to the same concentrations of the individual drugs. Combinations of ethambutol or rifampicin with streptomycin were more effective than the individual drugs alone. All strains of M malmoense were highly resistant to isoniazid, and susceptibility to either rifampicin, ethambutol, or streptomycin was unchanged or differed by only one tube when the drugs were combined with isoniazid (results not shown). Table 3 
Discussion
The patterns of resistance to the major antituberculosis drugs in this study are characteristic of the three mycobacterial species studied, which are often fully sensitive in vitro only to second line agents-for example, cycloserine and ethionamide. Treatment regimens tailored to these results have not, however, been generally successful, probably because of drug toxicity and poor compliance by patients. Because of their clinical and radiographic abnormalities and sputum smear results many patients with non-tuberculous mycobacterial disease are initially misdiagnosed as having classical M tuberculosis and started on treatment with standard antituberculosis drugs. In most of them treatment will be successful despite the subsequent reports of in vitro resistance to one or more of the individual drugs prescribed. Alterations to such successful regimens made on the basis of the sensitivity results should be avoided. Sensitivity testing of drug combinations might yield results that agree more closely with clinical response but a prospective study is needed to confirm this.
